Ategra Capital Management, LLC Gsk PLC Transaction History

Ategra Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Feb 13, 2025	SELL	$16.13 - $44.61 $112,764 - $311,868	-6,991 Closed	0 $0
Q2 2022 Feb 13, 2025	SELL	$42.05 - $47.77 $55,632 - $63,199	-1,323 Reduced 15.91%	6,991 $304 Million
Q1 2022 Feb 13, 2025	SELL	$40.23 - $47.74 $35,844 - $42,536	-891 Reduced 9.68%	8,314 $362 Million
Q4 2021 Feb 13, 2025	SELL	$38.88 - $45.31 $18,468 - $21,522	-475 Reduced 4.91%	9,205 $406 Million
Q3 2021 Feb 13, 2025	SELL	$38.79 - $43.16 $61,133 - $68,020	-1,576 Reduced 14.0%	9,680 $370 Million
Q2 2021 Feb 13, 2025	SELL	$36.52 - $41.46 $6,317 - $7,172	-173 Reduced 1.51%	11,256 $448 Million
Q1 2021 Feb 13, 2025	BUY	$34.27 - $40.01 $2,467 - $2,880	72 Added 0.63%	11,429 $408 Million
Q4 2020 Feb 13, 2025	BUY	$34.07 - $39.94 $131,407 - $154,048	3,857 Added 51.43%	11,357 $418 Million
Q3 2020 Feb 13, 2025	BUY	$38.11 - $42.99 $38,491 - $43,419	1,010 Added 15.56%	7,500 $282 Million
Q3 2019 Feb 13, 2025	SELL	$40.46 - $43.52 $31,275 - $33,640	-773 Reduced 10.64%	6,490 $277 Million
Q2 2019 Feb 13, 2025	SELL	$39.4 - $42.7 $12,923 - $14,005	-328 Reduced 4.32%	7,263 $291 Million
Q1 2019 Feb 13, 2025	BUY	$38.57 - $42.69 $292,784 - $324,059	7,591 New	7,591 $317 Million

167K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $75.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Ategra Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ategra Capital Management, LLC with notifications on news.